2013 Form 10-K Financial Statement

#000088559014000025 Filed on February 28, 2014

View on sec.gov

Income Statement

Concept 2013 2012 Q4 2012
Revenue $5.770B $920.1M $3.480B
YoY Change 65.77% 33.64% 43.38%
Cost Of Revenue $1.846B $217.8M $905.1M
YoY Change 103.99% 17.98% 32.37%
Gross Profit $3.923B $702.2M $2.575B
YoY Change 52.34% 39.38% 47.69%
Gross Profit Margin 68.0% 76.32% 73.99%
Selling, General & Admin $1.305B $204.7M $756.1M
YoY Change 72.62% 37.85% 32.08%
% of Gross Profit 33.27% 29.15% 29.36%
Research & Development $156.8M $20.20M $79.10M
YoY Change 98.23% 20.24% 20.42%
% of Gross Profit 4.0% 2.88% 3.07%
Depreciation & Amortization $114.0M $313.4M $54.80M
YoY Change 108.03% 50.38% 20.18%
% of Gross Profit 2.91% 44.63% 2.13%
Operating Expenses $1.462B $604.3M $835.2M
YoY Change 75.05% 68.75% 30.88%
Operating Profit -$409.5M $97.90M $79.70M
YoY Change -613.8% -32.81% -73.43%
Interest Expense -$840.0M -$158.9M -$454.0M
YoY Change 85.02% 135.06% 61.57%
% of Operating Profit -162.31% -569.64%
Other Income/Expense, Net $234.4M $59.35M
YoY Change 295.02% 802.65%
Pretax Income -$574.5M -$274.6M -$205.6M
YoY Change 179.43% 258.02% 396.93%
Income Tax -$450.8M -$185.5M -$278.2M
% Of Pretax Income
Net Earnings -$863.6M -$89.10M -$116.0M
YoY Change 644.48% -259.39% -172.7%
Net Earnings / Revenue -14.97% -9.68% -3.33%
Basic Earnings Per Share -$2.70 -$0.38
Diluted Earnings Per Share -$2.70 -$292.1K -$0.38
COMMON SHARES
Basic Shares Outstanding 321.0M shares 304.8M shares 305.4M shares
Diluted Shares Outstanding 321.0M shares 305.4M shares

Balance Sheet

Concept 2013 2012 Q4 2012
SHORT-TERM ASSETS
Cash & Short-Term Investments $600.0M $920.5M $916.0M
YoY Change -34.5% 440.08% 438.82%
Cash & Equivalents $600.0M $916.1M $916.0M
Short-Term Investments $4.410M
Other Short-Term Assets $726.0M $416.0M $416.0M
YoY Change 74.52% 58.17% 58.17%
Inventory $883.0M $531.3M $531.0M
Prepaid Expenses
Receivables $1.676B $769.5M $769.0M
Other Receivables $0.00 $0.00 $145.0M
Total Short-Term Assets $3.886B $2.777B $2.777B
YoY Change 39.94% 104.6% 104.49%
LONG-TERM ASSETS
Property, Plant & Equipment $1.234B $462.7M $463.0M
YoY Change 166.52% 11.7% 11.84%
Goodwill $5.141B
YoY Change 43.55%
Intangibles $9.309B
YoY Change 21.82%
Long-Term Investments
YoY Change
Other Assets $250.0M $183.7M $260.0M
YoY Change -3.85% 213.03% 130.09%
Total Long-Term Assets $24.09B $15.17B $15.17B
YoY Change 58.74% 29.12% 29.13%
TOTAL ASSETS
Total Short-Term Assets $3.886B $2.777B $2.777B
Total Long-Term Assets $24.09B $15.17B $15.17B
Total Assets $27.97B $17.95B $17.95B
YoY Change 55.83% 36.94% 36.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $327.0M $227.4M $227.0M
YoY Change 44.05% 44.26% 43.67%
Accrued Expenses $1.800B $1.008B $971.0M
YoY Change 85.38% 91.1% 83.9%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $10.55M $11.00M
YoY Change -100.0%
Long-Term Debt Due $205.0M $480.2M $480.0M
YoY Change -57.29% 331.62% 332.43%
Total Short-Term Liabilities $2.513B $1.823B $1.823B
YoY Change 37.85% 97.21% 97.29%
LONG-TERM LIABILITIES
Long-Term Debt $17.16B $10.54B $10.54B
YoY Change 62.91% 61.1% 61.09%
Other Long-Term Liabilities $743.0M $165.0M $626.0M
YoY Change 18.69% 115.14% 19.01%
Total Long-Term Liabilities $17.91B $10.70B $11.16B
YoY Change 60.43% 61.72% 57.95%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.513B $1.823B $1.823B
Total Long-Term Liabilities $17.91B $10.70B $11.16B
Total Liabilities $22.85B $14.23B $14.23B
YoY Change 60.56% 55.07% 55.08%
SHAREHOLDERS EQUITY
Retained Earnings -$2.371B
YoY Change 16.78%
Common Stock $6.208B
YoY Change -0.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.119B $3.717B $3.717B
YoY Change
Total Liabilities & Shareholders Equity $27.97B $17.95B $17.95B
YoY Change 55.83% 36.94% 36.94%

Cashflow Statement

Concept 2013 2012 Q4 2012
OPERATING ACTIVITIES
Net Income -$863.6M -$89.10M -$116.0M
YoY Change 644.48% -259.39% -172.7%
Depreciation, Depletion And Amortization $114.0M $313.4M $54.80M
YoY Change 108.03% 50.38% 20.18%
Cash From Operating Activities $1.042B $67.90M $656.6M
YoY Change 58.7% -64.23% 2.51%
INVESTING ACTIVITIES
Capital Expenditures $115.3M -$90.40M $107.6M
YoY Change 7.16% 368.39% 83.88%
Acquisitions $5.254B $3.485B
YoY Change 50.73% 41.44%
Other Investing Activities -$5.195B -$1.883B -$2.785B
YoY Change 86.58% 25.99% 14.94%
Cash From Investing Activities -$5.380B -$1.974B -$2.966B
YoY Change 81.42% 30.37% 5.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$2.252B $280.7M
YoY Change -902.21% -56.09%
Debt Paid & Issued, Net $6.326B $1.929B
YoY Change 227.94% -3.77%
Cash From Financing Activities $4.028B 2.562B $3.057B
YoY Change 31.74% 107.21% 56.93%
NET CHANGE
Cash From Operating Activities $1.042B 67.90M $656.6M
Cash From Investing Activities -$5.380B -1.974B -$2.966B
Cash From Financing Activities $4.028B 2.562B $3.057B
Net Change In Cash -$310.6M 656.4M $748.2M
YoY Change -141.51% -849.32% -440.4%
FREE CASH FLOW
Cash From Operating Activities $1.042B $67.90M $656.6M
Capital Expenditures $115.3M -$90.40M $107.6M
Free Cash Flow $926.7M $158.3M $549.0M
YoY Change 68.8% -24.29% -5.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
128760000 USD
CY2013Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
117285000 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
326970000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
227384000 USD
CY2013Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1704015000 USD
CY2012Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
781954000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
769469000 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1676339000 USD
CY2013Q4 us-gaap Accrued Advertising Current
AccruedAdvertisingCurrent
8507000 USD
CY2012Q4 us-gaap Accrued Advertising Current
AccruedAdvertisingCurrent
11432000 USD
CY2013Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
201223000 USD
CY2012Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
69345000 USD
CY2013Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
39097000 USD
CY2012Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
19910000 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1800193000 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1008224000 USD
CY2012Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
29950000 USD
CY2013Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
46271000 USD
CY2013Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
37590000 USD
CY2012Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
24523000 USD
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
173508000 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
838842000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-119396000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-132780000 USD
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-279616000 USD
CY2010Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
98836000 USD
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
267118000 USD
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
228853000 USD
CY2013 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
-46588000 USD
CY2011 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
-37702000 USD
CY2012 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
-31073000 USD
CY2011 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
94023000 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
45478000 USD
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
66236000 USD
CY2011 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
26414000 USD
CY2012 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
12541000 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
24200000 USD
CY2012 us-gaap Advertising Expense
AdvertisingExpense
157600000 USD
CY2013 us-gaap Advertising Expense
AdvertisingExpense
277300000 USD
CY2011 us-gaap Advertising Expense
AdvertisingExpense
106300000 USD
CY2011 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
94023000 USD
CY2012 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
66236000 USD
CY2013 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
45478000 USD
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
27676000 USD
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
12485000 USD
CY2011 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
27103000 USD
CY2013 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
89461000 USD
CY2012 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
36402000 USD
CY2011 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
566989000 USD
CY2012 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
931442000 USD
CY2013 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1901977000 USD
CY2013Q4 us-gaap Assets
Assets
27970797000 USD
CY2012Q4 us-gaap Assets
Assets
17950379000 USD
CY2011Q4 us-gaap Assets
Assets
13108119000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
3885889000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
2777451000 USD
CY2013Q4 us-gaap Assets Held For Sale Current
AssetsHeldForSaleCurrent
15942000 USD
CY2012Q4 us-gaap Assets Held For Sale Current
AssetsHeldForSaleCurrent
90983000 USD
CY2012Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
11577000 USD
CY2013Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
0 USD
CY2012Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
11197000 USD
CY2013Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
0 USD
CY2012Q3 us-gaap Business Acquisition Preacquisition Contingency Amount Of Settlement
BusinessAcquisitionPreacquisitionContingencyAmountOfSettlement
12000000 USD
CY2012 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-709592000 USD
CY2013 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-821147000 USD
CY2013 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
7665850000 USD
CY2012 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
7700624000 USD
CY2011 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
32964000 USD
CY2013 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
36416000 USD
CY2012 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
78604000 USD
CY2012 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
5266000 USD
CY2011 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
10986000 USD
CY2013 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
29259000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
600340000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
916091000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
164111000 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
394269000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
306604000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
171339000 USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2012Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
333036637 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
303861272 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
333036637 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
303861272 shares
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
5940652000 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
8301179000 USD
CY2013 us-gaap Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Reclassifications </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain reclassifications have been made to prior year amounts to conform to the current year presentation.</font></div><div style="line-height:120%;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, the Company has made a reclassification to the 2012 and 2011 consolidated statements of (loss) income for the presentation of proceeds from the out-license or sale of non-core products to conform to the current year presentation. To enhance comparability of the Company&#8217;s revenues and expenses from period to period and to the Company&#8217;s peers, the Company no longer records the proceeds on the sale of non-core products as Alliance and royalty revenue, with the associated costs, including the carrying amount of related assets, recorded as Cost of alliance and service revenues. Rather, effective in 2013, the Company nets the proceeds with the carrying amount of related assets and records a gain/loss on sale within Other expense. </font></div><div style="line-height:120%;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-879526000 USD
CY2012 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
44195000 USD
CY2011 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-218893000 USD
CY2013 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
2804000 USD
CY2012 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
CY2011 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
CY2013 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-876722000 USD
CY2011 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-218893000 USD
CY2012 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
44195000 USD
CY2013 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Concentrations of Credit Risk </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities and accounts receivable.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company invests its excess cash in high-quality, money market instruments and term deposits with varying maturities, but typically less than </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months.</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font><font style="font-family:inherit;font-size:10pt;">The Company maintains its cash and cash equivalents with major financial institutions. The Company has not experienced any significant losses on its cash or cash equivalents.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In 2012, the Company&#8217;s marketable securities portfolio included the investment in auction rate floating securities (student loans) and the investment in equity securities acquired in connection with the Medicis Acquisition. The investment in auction rate floating securities had a maximum term to maturity of </font><font style="font-family:inherit;font-size:10pt;">34</font><font style="font-family:inherit;font-size:10pt;"> years.</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font><font style="font-family:inherit;font-size:10pt;">In 2013, the Company sold its entire investment in auction rate securities assumed in connection with the Medicis Acquisition. In 2011, the Company&#8217;s marketable securities portfolio included investment-grade corporate enterprise fixed income debt securities that matured within </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> year.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s accounts receivable primarily arise from product sales in the U.S. and Europe and primarily represent amounts due from wholesale distributors, retail pharmacies, government entities and group purchasing organizations. Outside of the U.S., concentrations of credit risk with respect to trade receivables, which are typically unsecured, are limited due to the number of customers using the Company&#8217;s products, as well as their dispersion across many different geographic areas. The Company performs periodic credit evaluations of customers and does not require collateral. The Company monitors economic conditions, including volatility associated with international economies, and related impacts on the relevant financial markets and its business, especially in light of sovereign credit issues. The credit and economic conditions within Italy, Portugal, Spain and Greece, among other members of the European Union, have deteriorated. These conditions have increased, and may continue to increase, the average length of time that it takes to collect on the Company&#8217;s accounts receivable outstanding in these countries. An allowance for doubtful accounts is maintained for potential credit losses based on the aging of accounts receivable, historical bad debts experience, and changes in customer payment patterns. Accounts receivables balances are written off against the allowance when it is probable that the receivable will not be&#160;collected.</font></div></div>
CY2013Q4 us-gaap Contractual Obligation
ContractualObligation
53000000 USD
CY2011 us-gaap Cost Of Goods Sold
CostOfGoodsSold
683750000 USD
CY2013 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1846314000 USD
CY2012 us-gaap Cost Of Goods Sold
CostOfGoodsSold
905095000 USD
CY2011 us-gaap Cost Of Goods Sold Amortization
CostOfGoodsSoldAmortization
8103000 USD
CY2012 us-gaap Cost Of Goods Sold Amortization
CostOfGoodsSoldAmortization
2557000 USD
CY2013 us-gaap Cost Of Goods Sold Amortization
CostOfGoodsSoldAmortization
0 USD
CY2012 us-gaap Cost Of Services Licenses And Services
CostOfServicesLicensesAndServices
64601000 USD
CY2013 us-gaap Cost Of Services Licenses And Services
CostOfServicesLicensesAndServices
58806000 USD
CY2011 us-gaap Cost Of Services Licenses And Services
CostOfServicesLicensesAndServices
12348000 USD
CY2012 us-gaap Costs And Expenses
CostsAndExpenses
3400691000 USD
CY2013 us-gaap Costs And Expenses
CostsAndExpenses
6179107000 USD
CY2011 us-gaap Costs And Expenses
CostsAndExpenses
2127491000 USD
CY2011 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
3554000 USD
CY2013 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
3403000 USD
CY2012 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
7189000 USD
CY2012 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
56337000 USD
CY2013 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
80010000 USD
CY2011 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
36337000 USD
CY2013 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
83413000 USD
CY2011 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
39891000 USD
CY2012 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
63526000 USD
CY2013Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
17636936000 USD
CY2013Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
269234000 USD
CY2012 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-11886000 USD
CY2011 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-21763000 USD
CY2013 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 USD
CY2013 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-534196000 USD
CY2011 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-195687000 USD
CY2012 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-329843000 USD
CY2013 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-534196000 USD
CY2012 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-341729000 USD
CY2011 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-217450000 USD
CY2013Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
12549000 USD
CY2012Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
60850000 USD
CY2012Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
945838000 USD
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1978518000 USD
CY2012Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
-981286000 USD
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
-1963363000 USD
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
366914000 USD
CY2012Q4 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
195007000 USD
CY2012Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
821323000 USD
CY2013Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1500945000 USD
CY2012Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
76422000 USD
CY2013Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
54942000 USD
CY2012Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
23453000 USD
CY2013Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
76464000 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
126415000 USD
CY2012Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
77426000 USD
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
19828000 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
42987000 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
577509000 USD
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
211486000 USD
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
477573000 USD
CY2012Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
124515000 USD
CY2012 us-gaap Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
-12541000 USD
CY2013 us-gaap Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
-24200000 USD
CY2011 us-gaap Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
-26533000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1802609000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
3464308000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
4403000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
66017000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
1610386000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
2884288000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
1248312000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
2319202000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Tax Deferred Income
DeferredTaxLiabilitiesTaxDeferredIncome
7032000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Tax Deferred Income
DeferredTaxLiabilitiesTaxDeferredIncome
19487000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Undistributed Foreign Earnings
DeferredTaxLiabilitiesUndistributedForeignEarnings
563775000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Undistributed Foreign Earnings
DeferredTaxLiabilitiesUndistributedForeignEarnings
191129000 USD
CY2013Q4 us-gaap Defined Benefit Plan Accumulated Other Comprehensive Income Net Prior Service Cost Credit After Tax
DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax
-27900000 USD
CY2013 us-gaap Defined Benefit Plan Effect Of One Percentage Point Decrease On Accumulated Postretirement Benefit Obligation1
DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1
933000 USD
CY2013 us-gaap Defined Benefit Plan Effect Of One Percentage Point Increase On Accumulated Postretirement Benefit Obligation
DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation
1009000 USD
CY2013 us-gaap Defined Benefit Plan Future Amortization Of Prior Service Cost Credit
DefinedBenefitPlanFutureAmortizationOfPriorServiceCostCredit
-2500000 USD
CY2013 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
16400000 USD
CY2011 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
2100000 USD
CY2012 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
2800000 USD
CY2011 us-gaap Depreciation
Depreciation
45600000 USD
CY2012 us-gaap Depreciation
Depreciation
54800000 USD
CY2013 us-gaap Depreciation
Depreciation
113800000 USD
CY2011 us-gaap Depreciation And Amortization
DepreciationAndAmortization
612603000 USD
CY2012 us-gaap Depreciation And Amortization
DepreciationAndAmortization
986222000 USD
CY2013 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2015806000 USD
CY2013 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.70
CY2011 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.52
CY2012 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.38
CY2011 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.49
CY2012 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.38
CY2013 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.70
CY2012 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
3755000 USD
CY2011 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-10288000 USD
CY2013 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-5074000 USD
CY2011 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.283
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.269
CY2012 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.269
CY2012 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
12541000 USD
CY2013 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
24200000 USD
CY2011 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
26533000 USD
CY2013 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
29259000 USD
CY2012 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
5266000 USD
CY2013 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
4938000 USD
CY2012 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
-784000 USD
CY2013 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
141184000 USD
CY2012 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
106248000 USD
CY2012Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
455082000 USD
CY2011Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
420084000 USD
CY2013Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
355765000 USD
CY2013 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P9Y
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3827408000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1997626000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1406660000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1088496000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1213345000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1278275000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1368548000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
10759419000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
14398719000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10571311000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8761793000 USD
CY2013 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-9465000 USD
CY2012 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
19721000 USD
CY2011 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
26551000 USD
CY2012 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
23839000 USD
CY2011 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
4829000 USD
CY2013 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-9783000 USD
CY2013 us-gaap Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
-353588000 USD
CY2012 us-gaap Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
-106047000 USD
CY2011 us-gaap Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
-5085000 USD
CY2013 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-10180000 USD
CY2011 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
5314000 USD
CY2012 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-10780000 USD
CY2011 us-gaap Gain Loss On Investments
GainLossOnInvestments
22776000 USD
CY2012 us-gaap Gain Loss On Investments
GainLossOnInvestments
2056000 USD
CY2013 us-gaap Gain Loss On Investments
GainLossOnInvestments
5822000 USD
CY2013 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-220495000 USD
CY2012 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-56779000 USD
CY2011 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-11841000 USD
CY2013 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
3963000 USD
CY2012 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
2056000 USD
CY2011 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
22776000 USD
CY2011 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-36844000 USD
CY2012 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-20080000 USD
CY2013 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-65014000 USD
CY2013Q4 us-gaap Goodwill
Goodwill
9752100000 USD
CY2012Q4 us-gaap Goodwill
Goodwill
5141366000 USD
CY2011Q4 us-gaap Goodwill
Goodwill
3581512000 USD
CY2013 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
4595184000 USD
CY2012 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
1516592000 USD
CY2013 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
28152000 USD
CY2012 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-14631000 USD
CY2012 us-gaap Goodwill Translation Adjustments
GoodwillTranslationAdjustments
57893000 USD
CY2013 us-gaap Goodwill Translation Adjustments
GoodwillTranslationAdjustments
-12602000 USD
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-205612000 USD
CY2011 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-41374000 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-574527000 USD
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-188616000 USD
CY2011 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
23374000 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-739925000 USD
CY2011 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-18000000 USD
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-394228000 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1314452000 USD
CY2011 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-177559000 USD
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-450783000 USD
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-278203000 USD
CY2013 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
143945000 USD
CY2011 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-57249000 USD
CY2012 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-34245000 USD
CY2012 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-4459000 USD
CY2011 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-18313000 USD
CY2013 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
6555000 USD
CY2013 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-407604000 USD
CY2011 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-180301000 USD
CY2012 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-226764000 USD
CY2011 us-gaap Income Tax Reconciliation Nondeductible Expense Amortization
IncomeTaxReconciliationNondeductibleExpenseAmortization
22251000 USD
CY2013 us-gaap Income Tax Reconciliation Nondeductible Expense Amortization
IncomeTaxReconciliationNondeductibleExpenseAmortization
0 USD
CY2012 us-gaap Income Tax Reconciliation Nondeductible Expense Amortization
IncomeTaxReconciliationNondeductibleExpenseAmortization
6173000 USD
CY2011 us-gaap Income Tax Reconciliation Nondeductible Expense Research And Development
IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment
0 USD
CY2013 us-gaap Income Tax Reconciliation Nondeductible Expense Research And Development
IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment
0 USD
CY2012 us-gaap Income Tax Reconciliation Nondeductible Expense Research And Development
IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment
3228000 USD
CY2013 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
13096000 USD
CY2011 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
14045000 USD
CY2012 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
6258000 USD
CY2012 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-3781000 USD
CY2011 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
205000 USD
CY2013 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
21917000 USD
CY2012 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
3056000 USD
CY2013 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
0 USD
CY2011 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
15384000 USD
CY2013 us-gaap Income Taxes Paid
IncomeTaxesPaid
65072000 USD
CY2012 us-gaap Income Taxes Paid
IncomeTaxesPaid
41425000 USD
CY2011 us-gaap Income Taxes Paid
IncomeTaxesPaid
45399000 USD
CY2012 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-8370000 USD
CY2011 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
42067000 USD
CY2013 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-76548000 USD
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
261380000 USD
CY2012 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
219431000 USD
CY2011 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
164581000 USD
CY2013 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
122701000 USD
CY2012 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
80304000 USD
CY2011 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
11521000 USD
CY2012 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-54827000 USD
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-82338000 USD
CY2011 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3084000 USD
CY2013 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
0 USD
CY2011 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
0 USD
CY2012 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
8872000 USD
CY2012 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2011 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
12980000 shares
CY2013 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2012 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2011 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
8484000 shares
CY2013 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2013Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
16675568000 USD
CY2012Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
11306295000 USD
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9308669000 USD
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12848160000 USD
CY2011 us-gaap Interest And Debt Expense
InterestAndDebtExpense
334526000 USD
CY2012 us-gaap Interest And Debt Expense
InterestAndDebtExpense
481596000 USD
CY2013 us-gaap Interest And Debt Expense
InterestAndDebtExpense
844316000 USD
CY2013 us-gaap Investment Income Interest
InvestmentIncomeInterest
8023000 USD
CY2011 us-gaap Investment Income Interest
InvestmentIncomeInterest
4084000 USD
CY2012 us-gaap Investment Income Interest
InvestmentIncomeInterest
5986000 USD
CY2012 us-gaap Interest Paid
InterestPaid
421019000 USD
CY2013 us-gaap Interest Paid
InterestPaid
652910000 USD
CY2011 us-gaap Interest Paid
InterestPaid
247879000 USD
CY2012Q4 us-gaap Interest Payable Current
InterestPayableCurrent
131462000 USD
CY2013Q4 us-gaap Interest Payable Current
InterestPayableCurrent
227423000 USD
CY2013Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
656305000 USD
CY2012Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
406018000 USD
CY2013Q4 us-gaap Inventory Gross
InventoryGross
982811000 USD
CY2012Q4 us-gaap Inventory Gross
InventoryGross
587287000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
531256000 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
882966000 USD
CY2013Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
221762000 USD
CY2012Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
120885000 USD
CY2013Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
99845000 USD
CY2012Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
56031000 USD
CY2012Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
60384000 USD
CY2013Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
104744000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
14232981000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
22737475000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17950379000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27970797000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1822752000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2512396000 USD
CY2012Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
14395000 USD
CY2013Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
8667000 USD
CY2012Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
103658000 USD
CY2013Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
169117000 USD
CY2012Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
16279000 USD
CY2013Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
55925000 USD
CY2013Q3 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
300000 USD
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
4027752000 USD
CY2011 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-2808508000 USD
CY2013 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-5380386000 USD
CY2013Q4 us-gaap Long Term Debt
LongTermDebt
17367702000 USD
CY2012Q4 us-gaap Long Term Debt
LongTermDebt
11015625000 USD
CY2012Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
480182000 USD
CY2013Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
204756000 USD
CY2013Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
18375289000 USD
CY2012Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
11691338000 USD
CY2013Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
11862803000 USD
CY2013Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
204756000 USD
CY2013Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
3497814000 USD
CY2013Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
954215000 USD
CY2013Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
744814000 USD
CY2013Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
372534000 USD
CY2013Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
17162946000 USD
CY2012Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
10535443000 USD
CY2011 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
22776000 USD
CY2012 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
2056000 USD
CY2013 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
5822000 USD
CY2013Q4 us-gaap Minority Interest
MinorityInterest
114599000 USD
CY2012Q4 us-gaap Minority Interest
MinorityInterest
0 USD
CY2013 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
2101000 USD
CY2011 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
58320000 USD
CY2013 us-gaap Nature Of Operations
NatureOfOperations
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DESCRIPTION OF BUSINESS</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valeant Pharmaceuticals International,&#160;Inc. (the&#160;&#8220;Company&#8221;) is a multinational, specialty pharmaceutical and medical device company that develops, manufactures, and markets a broad range of branded, generic and branded generic pharmaceuticals, over-the-counter (&#8220;OTC&#8221;) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices), which are marketed directly or indirectly in over </font><font style="font-family:inherit;font-size:10pt;">100</font><font style="font-family:inherit;font-size:10pt;"> countries. Effective August 9, 2013, the Company continued from the federal jurisdiction of Canada to the Province of British Columbia, meaning that the Company became a company registered under the laws of the Province of British Columbia as if it had been incorporated under the laws of the Province of British Columbia. As a result of this continuance, the legal domicile of the Company became the Province of British Columbia, the Canada Business Corporations Act ceased to apply to the Company and the Company became subject to the British Columbia Business Corporations Act (BCBCA).&#160;</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On August 5, 2013, the Company acquired Bausch &amp; Lomb Holdings Incorporated (&#8220;B&amp;L&#8221;), pursuant to an Agreement and Plan of Merger, as amended (the &#8220;Merger Agreement&#8221;) dated May 24, 2013, with B&amp;L surviving as a wholly-owned subsidiary of Valeant Pharmaceuticals International (&#8220;Valeant&#8221;), a wholly-owned subsidiary of the Company (the &#8220;B&amp;L Acquisition&#8221;). </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 11, 2012, the Company completed the acquisition of Medicis Pharmaceutical Corporation (&#8220;Medicis&#8221;) through a wholly-owned subsidiary pursuant to an Agreement and Plan of Merger, dated as of September 2, 2012, with Medicis surviving as a wholly-owned subsidiary of the Company (the &#8220;Medicis Acquisition&#8221;). </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For further information regarding the B&amp;L Acquisition and the Medicis Acquisition, see note 3 titled &#8220;BUSINESS COMBINATIONS&#8221;.</font></div></div>
CY2013 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-315751000 USD
CY2011 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-230158000 USD
CY2012 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
751980000 USD
CY2011 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1948165000 USD
CY2012 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
3057368000 USD
CY2012 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-2965721000 USD
CY2011 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
640473000 USD
CY2012 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
656578000 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
1041957000 USD
CY2013 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2473000 USD
CY2011 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2012 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2011 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
159559000 USD
CY2012 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-116025000 USD
CY2013 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-866142000 USD
CY2013 us-gaap Noncash Or Part Noncash Acquisition Debt Assumed1
NoncashOrPartNoncashAcquisitionDebtAssumed1
4264725000 USD
CY2012 us-gaap Noncash Or Part Noncash Acquisition Debt Assumed1
NoncashOrPartNoncashAcquisitionDebtAssumed1
825241000 USD
CY2011 us-gaap Noncash Or Part Noncash Acquisition Debt Assumed1
NoncashOrPartNoncashAcquisitionDebtAssumed1
0 USD
CY2013 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
113896000 USD
CY2011 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
58555000 USD
CY2011Q4 us-gaap Noncurrent Assets
NoncurrentAssets
414242000 USD
CY2012Q4 us-gaap Noncurrent Assets
NoncurrentAssets
462724000 USD
CY2013Q4 us-gaap Noncurrent Assets
NoncurrentAssets
1234236000 USD
CY2013Q4 us-gaap Number Of Countries In Which Entity Operates
NumberOfCountriesInWhichEntityOperates
100 country
CY2013 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segments
CY2013Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segments
CY2013 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segments
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-409502000 USD
CY2011 us-gaap Operating Income Loss
OperatingIncomeLoss
299959000 USD
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
79685000 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
269336000 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
66123000 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
22792000 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
28122000 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
38082000 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
48534000 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
65683000 USD
CY2011 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
18100000 USD
CY2013 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
51900000 USD
CY2012 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
22900000 USD
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
86261000 USD
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
186769000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
195470000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
183747000 USD
CY2012 us-gaap Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
0 USD
CY2013 us-gaap Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
-27944000 USD
CY2011 us-gaap Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
0 USD
CY2011 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
545000 USD
CY2013 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-37760000 USD
CY2012 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-259000 USD
CY2011 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-1046000 USD
CY2013 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
24492000 USD
CY2012 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-468000 USD
CY2011 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-381633000 USD
CY2013 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-50433000 USD
CY2012 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
161011000 USD
CY2011 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-377907000 USD
CY2012 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
159961000 USD
CY2013 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-50813000 USD
CY2013 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-50764000 USD
CY2011 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-381633000 USD
CY2012 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
161011000 USD
CY2013 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-210000 USD
CY2012 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
27000 USD
CY2011 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-53000 USD
CY2011 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
-2206000 USD
CY2012 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
0 USD
CY2013 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
0 USD
CY2011 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-378452000 USD
CY2012 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
160220000 USD
CY2013 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-13053000 USD
CY2012 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-259000 USD
CY2013 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-37760000 USD
CY2011 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
545000 USD
CY2012 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-1437000 USD
CY2011 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-21146000 USD
CY2013 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-3964000 USD
CY2012 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
0 USD
CY2011 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
0 USD
CY2013 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
15405000 USD
CY2013 us-gaap Other Expenses
OtherExpenses
234442000 USD
CY2011 us-gaap Other Expenses
OtherExpenses
6575000 USD
CY2012 us-gaap Other Expenses
OtherExpenses
59349000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
164968000 USD
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
160493000 USD
CY2013 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-466000 USD
CY2012 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
33693000 USD
CY2011 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
18418000 USD
CY2011 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
26541000 USD
CY2013 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
180849000 USD
CY2012 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
41800000 USD
CY2012 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
280724000 USD
CY2011 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
639242000 USD
CY2013 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
55629000 USD
CY2013 us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
0 USD
CY2012 us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
0 USD
CY2011 us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
66863000 USD
CY2012 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
33153000 USD
CY2011 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
40671000 USD
CY2013 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
128014000 USD
CY2013Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
30700000 USD
CY2012 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
31073000 USD
CY2011 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
59718000 USD
CY2013 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
65505000 USD
CY2013 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
5253543000 USD
CY2011 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
2464108000 USD
CY2012 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
3485286000 USD
CY2011 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
327437000 USD
CY2012 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
73495000 USD
CY2013 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
69636000 USD
CY2012 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
107638000 USD
CY2011 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
58515000 USD
CY2013 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
115319000 USD
CY2011 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
58515000 USD
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
115319000 USD
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
107638000 USD
CY2012 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
7200000 USD
CY2011 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
81087000 USD
CY2013 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0 USD
CY2011 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
0 USD
CY2013 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
2101000 USD
CY2012 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
0 USD
CY2012Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
5325000 USD
CY2013Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
172016000 USD
CY2013Q4 us-gaap Prepaid Advertising
PrepaidAdvertising
8800000 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
204958000 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
130279000 USD
CY2013 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2307436000 USD
CY2011 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2012 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2013 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
CY2011 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
613471000 USD
CY2013 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
8441356000 USD
CY2011 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
5388799000 USD
CY2012 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
6005758000 USD
CY2011 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
-52499000 USD
CY2013 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
0 USD
CY2012 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
0 USD
CY2011 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
86639000 USD
CY2013 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
17020000 USD
CY2012 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
624774000 USD
CY2013 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
41092000 USD
CY2012 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
91996000 USD
CY2011 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
36000000 USD
CY2012 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
35365000 USD
CY2013 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
27413000 USD
CY2011 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0 USD
CY2013 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10015000 USD
CY2012 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
23026000 USD
CY2011 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
41738000 USD
CY2013 us-gaap Profit Loss
ProfitLoss
-863669000 USD
CY2012 us-gaap Profit Loss
ProfitLoss
-116025000 USD
CY2011 us-gaap Profit Loss
ProfitLoss
159559000 USD
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
636232000 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2073078000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1234236000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
462724000 USD
CY2013Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
1814769000 USD
CY2012Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
913835000 USD
CY2012 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
3975000 USD
CY2013 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
6326219000 USD
CY2012 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1929118000 USD
CY2011 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2004641000 USD
CY2012 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
31075000 USD
CY2011 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0 USD
CY2013 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
75140000 USD
CY2013 us-gaap Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
76666000 USD
CY2011 us-gaap Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
35927000 USD
CY2012 us-gaap Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
86193000 USD
CY2012 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
79052000 USD
CY2013 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
156783000 USD
CY2011 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
65687000 USD
CY2012 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
189901000 USD
CY2011 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
109200000 USD
CY2013 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
153639000 USD
CY2013 us-gaap Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
500 employees
CY2012 us-gaap Restructuring Charges
RestructuringCharges
344387000 USD
CY2013 us-gaap Restructuring Charges
RestructuringCharges
514825000 USD
CY2011 us-gaap Restructuring Charges
RestructuringCharges
97667000 USD
CY2012Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
32798000 USD
CY2013Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
111972000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2370976000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3278529000 USD
CY2013 us-gaap Revenue Recognition Sales Of Goods
RevenueRecognitionSalesOfGoods
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Product Sales </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product sales revenue is recognized when title has transferred to the customer and the customer has assumed the risks and rewards of ownership, the timing of which is based on the specific contractual terms with each customer. In most instances, transfer of title as well as the risks and rewards of ownership occurs upon delivery of the product to the customer. Amounts received from customers as prepayments for products to be shipped in the future are recorded in deferred revenue. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue from product sales is recognized net of provisions for estimated discounts, allowances, returns, rebates, chargebacks and distribution fees paid to certain of our wholesale customers. The Company offers discounts for prompt payment and other incentive allowances to customers. Provisions for discounts and allowances are estimated based on contractual sales terms with customers and historical payment experience. The Company allows customers to return product within a specified period of time before and after its expiration date. Provisions for returns are estimated based on historical return levels, taking into account additional available information on competitive products and contract changes. The Company has data sharing agreements with the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> largest wholesalers in the U.S.&#160;Where the Company does not have data sharing agreements, it uses third party data to estimate the level of product inventories and product demand at wholesalers and retail pharmacies. The Company reviews its methodology and adequacy of the provision for returns on a quarterly basis, adjusting for changes in assumptions, historical results and business practices, as necessary. The Company is subject to rebates on sales made under governmental and commercial rebate programs, and chargebacks on sales made to government agencies, retail pharmacies and group purchasing organizations. Provisions for rebates and chargebacks are estimated based on historical experience, relevant statutes with respect to governmental pricing programs, and contractual sales&#160;terms.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the Medicis Acquisition, which was completed in December 2012, the Company acquired several brands, including the following aesthetics products: Dysport&#174;, Perlane&#174;, and Restylane&#174;. In 2012, consistent with legacy Medicis&#8217; historical approach, the Company recognized revenue on those products upon shipment from McKesson, the Company&#8217;s primary U.S. distributor of aesthetics products, to physicians. As part of its integration efforts, the Company implemented new strategies and business practices in the first quarter of 2013, particularly as they relate to rebate and discount programs for these aesthetics products. As a result of these changes, the criteria for revenue recognition are achieved upon shipment of these products to McKesson, and, therefore, the Company began, in 2013, recognizing revenue upon shipment of these products to McKesson. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is party to manufacturing and supply agreements with a number of commercialization counterparties in the U.S.&#160;Under the terms of these agreements, the Company&#8217;s supply prices for its products are determined after taking into consideration estimates for future returns, rebates, and chargebacks provided by each counterparty. The Company makes adjustments as needed to state these estimates on a basis consistent with this policy and its methodology for estimating returns, rebates and chargebacks related to its own direct product&#160;sales.</font></div></div>
CY2013 us-gaap Revenue Recognition Sales Of Services
RevenueRecognitionSalesOfServices
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Service and Other</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contract manufacturing service revenue is recognized when title of the manufactured products has transferred to the customer and the customer has assumed the risks and rewards of ownership.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development service revenue attributable to the performance of contract services is recognized as the services are performed, under the proportionate performance method of revenue recognition. Performance is measured based on units-of-work performed relative to total units-of-work contracted. Units-of-work is generally measured based on hours&#160;spent.</font></div></div>
CY2013 us-gaap Revenue Recognition Services Royalty Fees
RevenueRecognitionServicesRoyaltyFees
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Alliance and Royalty</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company earns royalties and profit share revenue as a result of the licensing of product rights to third parties. Royalties and profit share revenue are earned at the time the related product is sold by the licensee based on the terms of the specific licensing agreement and when the Company has no future obligations with respect to the royalty or profit share. The Company relies on financial information provided by licensees to estimate the amounts due to it under the related agreements. </font></div></div>
CY2013 us-gaap Revenues
Revenues
5769605000 USD
CY2011 us-gaap Revenues
Revenues
2427450000 USD
CY2012 us-gaap Revenues
Revenues
3480376000 USD
CY2013 us-gaap Royalty Revenue
RoyaltyRevenue
52606000 USD
CY2012 us-gaap Royalty Revenue
RoyaltyRevenue
105591000 USD
CY2011 us-gaap Royalty Revenue
RoyaltyRevenue
136473000 USD
CY2012Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
12892000 USD
CY2013Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
25872000 USD
CY2013 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
5640333000 USD
CY2011 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2255050000 USD
CY2012 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
3288592000 USD
CY2012 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
756083000 USD
CY2013 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1305164000 USD
CY2011 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
572472000 USD
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
66236000 USD
CY2011 us-gaap Share Based Compensation
ShareBasedCompensation
94023000 USD
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
45478000 USD
CY2013Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
12081000 USD
CY2012Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
10548000 USD
CY2012 us-gaap Stock Issued1
StockIssued1
0 USD
CY2011 us-gaap Stock Issued1
StockIssued1
892000000 USD
CY2013 us-gaap Stock Issued1
StockIssued1
0 USD
CY2013Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
27058824 shares
CY2011 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
225983000 USD
CY2012 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
-43768000 USD
CY2013 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2306880000 USD
CY2013Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2300000000 USD
CY2013 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
6510000 USD
CY2011 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
41717000 USD
CY2012 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
23023000 USD
CY2011 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
639242000 USD
CY2013 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
55629000 USD
CY2012 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
280724000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
5118723000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
3717398000 USD
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
4911096000 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
3929830000 USD
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3717398000 USD
CY2013Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5233322000 USD
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
127978000 USD
CY2011Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
102290000 USD
CY2010Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
110857000 USD
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
247536000 USD
CY2013 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
10801000 USD
CY2012 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
1396000 USD
CY2011 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
11268000 USD
CY2012Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
24300000 USD
CY2013Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
46400000 USD
CY2012 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
1300000 USD
CY2013 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
5700000 USD
CY2011 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
2701000 USD
CY2012 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
3492000 USD
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
60678000 USD
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
19543000 USD
CY2012 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
19036000 USD
CY2013 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
2045000 USD
CY2012 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
2000000 USD
CY2012Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
88800000 USD
CY2013Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
153400000 USD
CY2013 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In preparing the Company&#8217;s consolidated financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Significant estimates made by management include: provisions for product returns, rebates and chargebacks; useful lives of amortizable intangible assets and property, plant and equipment; expected future cash flows used in evaluating intangible assets for impairment; reporting unit fair values in testing goodwill for impairment; provisions for loss contingencies; provisions for income taxes, uncertain tax positions and realizability of deferred tax assets; and the allocation of the purchase price of acquired assets and businesses, including the fair value of contingent consideration. Under certain product manufacturing and supply agreements, management relies on estimates for future returns, rebates and chargebacks made by the Company&#8217;s commercialization counterparties. On an ongoing basis, management reviews its estimates to ensure that these estimates appropriately reflect changes in the Company&#8217;s business and new information as it becomes available. If historical experience and other factors used by management to make these estimates do not reasonably reflect future activity, the Company&#8217;s consolidated financial statements could be materially impacted.</font></div></div>
CY2013 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
353100000 USD
CY2012 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-4200000 USD
CY2013 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
320996000 shares
CY2012 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
305446000 shares
CY2011 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
326119000 shares
CY2013 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
320996000 shares
CY2011 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
304655000 shares
CY2012 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
305446000 shares
CY2012Q4 vrx Accrued Capital Expenditures Current
AccruedCapitalExpendituresCurrent
959000 USD
CY2013Q4 vrx Accrued Capital Expenditures Current
AccruedCapitalExpendituresCurrent
27197000 USD
CY2012Q4 vrx Accrued Product Rebate Current
AccruedProductRebateCurrent
369339000 USD
CY2013Q4 vrx Accrued Product Rebate Current
AccruedProductRebateCurrent
566655000 USD
CY2012Q4 vrx Accrued Product Return Current
AccruedProductReturnCurrent
171099000 USD
CY2013Q4 vrx Accrued Product Return Current
AccruedProductReturnCurrent
225457000 USD
CY2011 vrx Acquisition Accounting Adjustment On Inventory Sold
AcquisitionAccountingAdjustmentOnInventorySold
59256000 USD
CY2013 vrx Acquisition Accounting Adjustment On Inventory Sold
AcquisitionAccountingAdjustmentOnInventorySold
372450000 USD
CY2012 vrx Acquisition Accounting Adjustment On Inventory Sold
AcquisitionAccountingAdjustmentOnInventorySold
78822000 USD
CY2011 vrx Adjustments To Additional Paid In Capital Reclassification Of Deferred Share Units
AdjustmentsToAdditionalPaidInCapitalReclassificationOfDeferredShareUnits
9271000 USD
CY2013 vrx Allowances For Losses On Accounts Receivable And Inventories
AllowancesForLossesOnAccountsReceivableAndInventories
68283000 USD
CY2011 vrx Allowances For Losses On Accounts Receivable And Inventories
AllowancesForLossesOnAccountsReceivableAndInventories
5519000 USD
CY2012 vrx Allowances For Losses On Accounts Receivable And Inventories
AllowancesForLossesOnAccountsReceivableAndInventories
21779000 USD
CY2012 vrx Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
928885000 USD
CY2013 vrx Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
1901977000 USD
CY2011 vrx Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
557814000 USD
CY2012 vrx Amortization Of Intangible Assets Included In Alliance And Royalty Revenue
AmortizationOfIntangibleAssetsIncludedInAllianceAndRoyaltyRevenue
0 USD
CY2011 vrx Amortization Of Intangible Assets Included In Alliance And Royalty Revenue
AmortizationOfIntangibleAssetsIncludedInAllianceAndRoyaltyRevenue
1072000 USD
CY2012Q4 vrx Availablefor Sale Debt Securities Gross Unrealized Gain Accumulatedin Investments
AvailableforSaleDebtSecuritiesGrossUnrealizedGainAccumulatedinInvestments
380000 USD
CY2013Q4 vrx Availablefor Sale Debt Securities Gross Unrealized Gain Accumulatedin Investments
AvailableforSaleDebtSecuritiesGrossUnrealizedGainAccumulatedinInvestments
0 USD
CY2012Q4 vrx Availablefor Sale Debt Securities Gross Unrealized Loss Accumulatedin Investments
AvailableforSaleDebtSecuritiesGrossUnrealizedLossAccumulatedinInvestments
0 USD
CY2013Q4 vrx Availablefor Sale Debt Securities Gross Unrealized Loss Accumulatedin Investments
AvailableforSaleDebtSecuritiesGrossUnrealizedLossAccumulatedinInvestments
0 USD
CY2012 vrx Business Acquisition Cost Of Acquired Entity Liabilities Incurred Contingent Consideration At Fair Value
BusinessAcquisitionCostOfAcquiredEntityLiabilitiesIncurredContingentConsiderationAtFairValue
145728000 USD
CY2013 vrx Business Acquisition Cost Of Acquired Entity Liabilities Incurred Contingent Consideration At Fair Value
BusinessAcquisitionCostOfAcquiredEntityLiabilitiesIncurredContingentConsiderationAtFairValue
76064000 USD
CY2011 vrx Business Acquisition Cost Of Acquired Entity Liabilities Incurred Contingent Consideration At Fair Value
BusinessAcquisitionCostOfAcquiredEntityLiabilitiesIncurredContingentConsiderationAtFairValue
443481000 USD
CY2013 vrx Business Acquisition Pro Forma Acquisition Accounting Adjustment Of Inventory Sold
BusinessAcquisitionProFormaAcquisitionAccountingAdjustmentOfInventorySold
369900000 USD
CY2013 vrx Business Acquisition Pro Forma Acquisition Related Costs
BusinessAcquisitionProFormaAcquisitionRelatedCosts
25300000 USD
CY2013 vrx Business Acquisition Pro Forma Earnings Per Share Basicand Diluted
BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted
-2.47
CY2012 vrx Business Acquisition Pro Forma Earnings Per Share Basicand Diluted
BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted
-2.14
CY2013 vrx Business Acquisition Purchase Price Allocation Current Assets Inventory Adjustment
BusinessAcquisitionPurchasePriceAllocationCurrentAssetsInventoryAdjustment
372500000 USD
CY2012 vrx Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash
-5266000 USD
CY2013 vrx Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash
-29259000 USD
CY2011 vrx Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash
-10986000 USD
CY2011 vrx Deferred Income Tax Noncash Expense Benefit
DeferredIncomeTaxNoncashExpenseBenefit
-222959000 USD
CY2012 vrx Deferred Income Tax Noncash Expense Benefit
DeferredIncomeTaxNoncashExpenseBenefit
-319603000 USD
CY2013Q4 vrx Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
114460000 USD
CY2012Q4 vrx Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
102559000 USD
CY2012Q4 vrx Business Combination Contingent Consideration Noncurrent Liability
BusinessCombinationContingentConsiderationNoncurrentLiability
352523000 USD
CY2013Q4 vrx Business Combination Contingent Consideration Noncurrent Liability
BusinessCombinationContingentConsiderationNoncurrentLiability
241305000 USD
CY2013Q2 vrx Deferred Compensation Arrangementwith Individual Compensation Expense Increase Decrease Reclassificationof Award
DeferredCompensationArrangementwithIndividualCompensationExpenseIncreaseDecreaseReclassificationofAward
21300000 USD
CY2013 vrx Deferred Income Tax Noncash Expense Benefit
DeferredIncomeTaxNoncashExpenseBenefit
-515884000 USD
CY2013Q4 vrx Deferred Tax Assets Deferred Expense Deferred Financing And Share Issue Costs
DeferredTaxAssetsDeferredExpenseDeferredFinancingAndShareIssueCosts
0 USD
CY2012Q4 vrx Deferred Tax Assets Deferred Expense Deferred Financing And Share Issue Costs
DeferredTaxAssetsDeferredExpenseDeferredFinancingAndShareIssueCosts
118369000 USD
CY2012Q4 vrx Deferred Tax Assets Plant Equipment And Technology
DeferredTaxAssetsPlantEquipmentAndTechnology
7478000 USD
CY2013Q4 vrx Deferred Tax Assets Plant Equipment And Technology
DeferredTaxAssetsPlantEquipmentAndTechnology
38339000 USD
CY2013Q4 vrx Deferred Tax Assets Scientific Research And Experimental Development Pool
DeferredTaxAssetsScientificResearchAndExperimentalDevelopmentPool
62883000 USD
CY2012Q4 vrx Deferred Tax Assets Scientific Research And Experimental Development Pool
DeferredTaxAssetsScientificResearchAndExperimentalDevelopmentPool
65718000 USD
CY2013Q4 vrx Deferred Tax Assets Tax Credit Carryforwards Research And Development
DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopment
83669000 USD
CY2012Q4 vrx Deferred Tax Assets Tax Credit Carryforwards Research And Development
DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopment
67683000 USD
CY2013Q4 vrx Deferred Tax Assets Tax Loss Carryforwards
DeferredTaxAssetsTaxLossCarryforwards
957703000 USD
CY2012Q4 vrx Deferred Tax Assets Tax Loss Carryforwards
DeferredTaxAssetsTaxLossCarryforwards
293547000 USD
CY2012Q4 vrx Deferred Tax Liabilities Basis Difference Of Convertible Notes
DeferredTaxLiabilitiesBasisDifferenceOfConvertibleNotes
0 USD
CY2013Q4 vrx Deferred Tax Liabilities Basis Difference Of Convertible Notes
DeferredTaxLiabilitiesBasisDifferenceOfConvertibleNotes
16598000 USD
CY2013Q4 vrx Deferred Tax Liabilities Prepaid Expense
DeferredTaxLiabilitiesPrepaidExpense
-353000 USD
CY2012Q4 vrx Deferred Tax Liabilities Prepaid Expense
DeferredTaxLiabilitiesPrepaidExpense
1094000 USD
CY2012Q4 vrx Deferred Tax Liability Offsetby Deferred Financingand Share Issue Cost Assets
DeferredTaxLiabilityOffsetbyDeferredFinancingandShareIssueCostAssets
36300000 USD
CY2013 vrx Defined Benefit Plan Estimated Future Benefit Payments Period
DefinedBenefitPlanEstimatedFutureBenefitPaymentsPeriod
P10Y
CY2013Q4 vrx Estimated Unrecognized Tax Benefits Realized In Next Twelve Months
EstimatedUnrecognizedTaxBenefitsRealizedInNextTwelveMonths
8700000 USD
CY2012 vrx Gain Loss On Auction Rate Securities
GainLossOnAuctionRateSecurities
0 USD
CY2013 vrx Gain Loss On Auction Rate Securities
GainLossOnAuctionRateSecurities
1859000 USD
CY2011 vrx Gain Loss On Auction Rate Securities
GainLossOnAuctionRateSecurities
0 USD
CY2012 vrx Impairment For Products Discontinuation
ImpairmentForProductsDiscontinuation
13300000 USD
CY2011 vrx Income Tax Reconciliation Alternative Minimum And Other Taxes
IncomeTaxReconciliationAlternativeMinimumAndOtherTaxes
2513000 USD
CY2013 vrx Income Tax Reconciliation Alternative Minimum And Other Taxes
IncomeTaxReconciliationAlternativeMinimumAndOtherTaxes
0 USD
CY2012 vrx Income Tax Reconciliation Alternative Minimum And Other Taxes
IncomeTaxReconciliationAlternativeMinimumAndOtherTaxes
-4528000 USD
CY2012 vrx Income Tax Reconciliation Change In Operating Losses Valuation Allowance
IncomeTaxReconciliationChangeInOperatingLossesValuationAllowance
0 USD
CY2013 vrx Income Tax Reconciliation Change In Operating Losses Valuation Allowance
IncomeTaxReconciliationChangeInOperatingLossesValuationAllowance
70154000 USD
CY2011 vrx Income Tax Reconciliation Change In Operating Losses Valuation Allowance
IncomeTaxReconciliationChangeInOperatingLossesValuationAllowance
0 USD
CY2012 vrx Income Tax Reconciliation Deferred Intercompany Profit
IncomeTaxReconciliationDeferredIntercompanyProfit
-10371000 USD
CY2011 vrx Income Tax Reconciliation Deferred Intercompany Profit
IncomeTaxReconciliationDeferredIntercompanyProfit
0 USD
CY2013 vrx Income Tax Reconciliation Deferred Intercompany Profit
IncomeTaxReconciliationDeferredIntercompanyProfit
-5726000 USD
CY2013 vrx Income Tax Reconciliation Foreign Currency Transaction Gain
IncomeTaxReconciliationForeignCurrencyTransactionGain
635000 USD
CY2011 vrx Income Tax Reconciliation Foreign Currency Transaction Gain
IncomeTaxReconciliationForeignCurrencyTransactionGain
40667000 USD
CY2012 vrx Income Tax Reconciliation Foreign Currency Transaction Gain
IncomeTaxReconciliationForeignCurrencyTransactionGain
9098000 USD
CY2013 vrx Income Tax Reconciliation Foreign Withholding Tax
IncomeTaxReconciliationForeignWithholdingTax
3393000 USD
CY2011 vrx Income Tax Reconciliation Foreign Withholding Tax
IncomeTaxReconciliationForeignWithholdingTax
5473000 USD
CY2012 vrx Income Tax Reconciliation Foreign Withholding Tax
IncomeTaxReconciliationForeignWithholdingTax
7954000 USD
CY2012 vrx Income Tax Reconciliation Nondeductible Expense Merger And Acquisition Costs
IncomeTaxReconciliationNondeductibleExpenseMergerAndAcquisitionCosts
24210000 USD
CY2013 vrx Income Tax Reconciliation Nondeductible Expense Merger And Acquisition Costs
IncomeTaxReconciliationNondeductibleExpenseMergerAndAcquisitionCosts
1090000 USD
CY2011 vrx Income Tax Reconciliation Nondeductible Expense Merger And Acquisition Costs
IncomeTaxReconciliationNondeductibleExpenseMergerAndAcquisitionCosts
0 USD
CY2012 vrx Income Tax Reconciliation Taxable Foreign Income
IncomeTaxReconciliationTaxableForeignIncome
10675000 USD
CY2011 vrx Income Tax Reconciliation Taxable Foreign Income
IncomeTaxReconciliationTaxableForeignIncome
0 USD
CY2013 vrx Income Tax Reconciliation Taxable Foreign Income
IncomeTaxReconciliationTaxableForeignIncome
55350000 USD
CY2012 vrx Income Tax Reconciliation Uncertain Tax Positions
IncomeTaxReconciliationUncertainTaxPositions
15433000 USD
CY2013 vrx Income Tax Reconciliation Uncertain Tax Positions
IncomeTaxReconciliationUncertainTaxPositions
0 USD
CY2011 vrx Income Tax Reconciliation Uncertain Tax Positions
IncomeTaxReconciliationUncertainTaxPositions
-8568000 USD
CY2013 vrx Income Tax Reconciliation Unrecognized Tax Benefits
IncomeTaxReconciliationUnrecognizedTaxBenefits
0 USD
CY2012 vrx Income Tax Reconciliation Unrecognized Tax Benefits
IncomeTaxReconciliationUnrecognizedTaxBenefits
32019000 USD
CY2011 vrx Income Tax Reconciliation Unrecognized Tax Benefits
IncomeTaxReconciliationUnrecognizedTaxBenefits
22187000 USD
CY2013 vrx Loss Contingency Numberof Class Action Cases
LossContingencyNumberofClassActionCases
13 cases
CY2012 vrx Maximum Term Of Maturity Of Auction Rate Floating Securities
MaximumTermOfMaturityOfAuctionRateFloatingSecurities
P34Y
CY2011 vrx Maximum Term Of Original Maturity Of Marketable Securities
MaximumTermOfOriginalMaturityOfMarketableSecurities
P1Y
CY2013 vrx Maximum Term Of Original Maturity To Classify Instruments As Cash And Cash Equivalents
MaximumTermOfOriginalMaturityToClassifyInstrumentsAsCashAndCashEquivalents
P3M
CY2013 vrx Minimum Period To Classify Uncertain Tax Position Liabilities As Long Term Liabilities
MinimumPeriodToClassifyUncertainTaxPositionLiabilitiesAsLongTermLiabilities
P1Y
CY2013 vrx Numberof Geographic Reporting Units
NumberofGeographicReportingUnits
4 segments
CY2012 vrx Numberof Manufacturing Facilities Constructed
NumberofManufacturingFacilitiesConstructed
2 facility
CY2011 vrx Other Comprehensive Income Loss Pensionand Other Postretirement Benefit Plans Amortizationor Settlement Recognition
OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansAmortizationorSettlementRecognition
-448000 USD
CY2013 vrx Other Comprehensive Income Loss Pensionand Other Postretirement Benefit Plans Amortizationor Settlement Recognition
OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansAmortizationorSettlementRecognition
-519000 USD
CY2012 vrx Other Comprehensive Income Loss Pensionand Other Postretirement Benefit Plans Amortizationor Settlement Recognition
OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansAmortizationorSettlementRecognition
-754000 USD
CY2011 vrx Other Comprehensive Income Reclassification Adjustment For Auction Rate Securities Net Of Tax
OtherComprehensiveIncomeReclassificationAdjustmentForAuctionRateSecuritiesNetOfTax
0 USD
CY2013 vrx Other Comprehensive Income Reclassification Adjustment For Auction Rate Securities Net Of Tax
OtherComprehensiveIncomeReclassificationAdjustmentForAuctionRateSecuritiesNetOfTax
1000 USD
CY2012 vrx Other Comprehensive Income Reclassification Adjustment For Auction Rate Securities Net Of Tax
OtherComprehensiveIncomeReclassificationAdjustmentForAuctionRateSecuritiesNetOfTax
0 USD
CY2013 vrx Other Comprehensive Income Reclassification Adjustment For Debt Securities Net Of Tax
OtherComprehensiveIncomeReclassificationAdjustmentForDebtSecuritiesNetOfTax
0 USD
CY2012 vrx Other Comprehensive Income Reclassification Adjustment For Debt Securities Net Of Tax
OtherComprehensiveIncomeReclassificationAdjustmentForDebtSecuritiesNetOfTax
-197000 USD
CY2011 vrx Other Comprehensive Income Reclassification Adjustment For Debt Securities Net Of Tax
OtherComprehensiveIncomeReclassificationAdjustmentForDebtSecuritiesNetOfTax
0 USD
CY2011 vrx Other Comprehensive Income Reclassification Adjustment For Equity Securities Net Of Tax
OtherComprehensiveIncomeReclassificationAdjustmentForEquitySecuritiesNetOfTax
21146000 USD
CY2013 vrx Other Comprehensive Income Reclassification Adjustment For Equity Securities Net Of Tax
OtherComprehensiveIncomeReclassificationAdjustmentForEquitySecuritiesNetOfTax
3963000 USD
CY2012 vrx Other Comprehensive Income Reclassification Adjustment For Equity Securities Net Of Tax
OtherComprehensiveIncomeReclassificationAdjustmentForEquitySecuritiesNetOfTax
1634000 USD
CY2011 vrx Other Comprehensive Income Unrealized Holding Gain Loss On Equity Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnEquitySecuritiesArisingDuringPeriodNetOfTax
22780000 USD
CY2013 vrx Other Comprehensive Income Unrealized Holding Gain Loss On Equity Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnEquitySecuritiesArisingDuringPeriodNetOfTax
3584000 USD
CY2013 vrx Past Due Period For Accounts Receivable To Be Negligible
PastDuePeriodForAccountsReceivableToBeNegligible
P90D
CY2011 vrx Payment Of Accreted Interest On Contingent Consideration
PaymentOfAccretedInterestOnContingentConsideration
0 USD
CY2013 vrx Payment Of Accreted Interest On Contingent Consideration
PaymentOfAccretedInterestOnContingentConsideration
11124000 USD
CY2012 vrx Payment Of Accreted Interest On Contingent Consideration
PaymentOfAccretedInterestOnContingentConsideration
2322000 USD
CY2013 vrx Other Comprehensive Income Unrealized Holding Gain Loss On Auction Rate Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnAuctionRateSecuritiesArisingDuringPeriodNetOfTax
0 USD
CY2012 vrx Other Comprehensive Income Unrealized Holding Gain Loss On Auction Rate Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnAuctionRateSecuritiesArisingDuringPeriodNetOfTax
1000 USD
CY2011 vrx Other Comprehensive Income Unrealized Holding Gain Loss On Auction Rate Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnAuctionRateSecuritiesArisingDuringPeriodNetOfTax
0 USD
CY2013 vrx Other Comprehensive Income Unrealized Holding Gain Loss On Debt Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnDebtSecuritiesArisingDuringPeriodNetOfTax
0 USD
CY2011 vrx Other Comprehensive Income Unrealized Holding Gain Loss On Debt Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnDebtSecuritiesArisingDuringPeriodNetOfTax
-114000 USD
CY2012 vrx Other Comprehensive Income Unrealized Holding Gain Loss On Debt Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnDebtSecuritiesArisingDuringPeriodNetOfTax
7000 USD
CY2012 vrx Other Comprehensive Income Unrealized Holding Gain Loss On Equity Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnEquitySecuritiesArisingDuringPeriodNetOfTax
379000 USD
CY2012 vrx Payments Of Contingent Consideration
PaymentsOfContingentConsideration
103926000 USD
CY2013 vrx Payments Of Contingent Consideration
PaymentsOfContingentConsideration
130060000 USD
CY2011 vrx Payments Of Contingent Consideration
PaymentsOfContingentConsideration
31800000 USD
CY2013 vrx Period Receivable Outstanding
PeriodReceivableOutstanding
P90D
CY2012 vrx Potential Weighted Average Number Of Diluted Shares Outstanding
PotentialWeightedAverageNumberOfDilutedSharesOutstanding
313124000 shares
CY2013 vrx Potential Weighted Average Number Of Diluted Shares Outstanding
PotentialWeightedAverageNumberOfDilutedSharesOutstanding
327466000 shares
CY2013 vrx Reporting Units Number
ReportingUnitsNumber
3 segments
CY2012 vrx Repurchase Of Equity Component Of Convertible Debt
RepurchaseOfEquityComponentOfConvertibleDebt
2862000 USD
CY2011 vrx Repurchase Of Equity Component Of Convertible Debt
RepurchaseOfEquityComponentOfConvertibleDebt
414003000 USD
CY2013Q4 vrx Royalties Current
RoyaltiesCurrent
21145000 USD
CY2012Q4 vrx Royalties Current
RoyaltiesCurrent
15606000 USD
CY2013Q2 vrx Saleof Stock Public Offering Price Per Share
SaleofStockPublicOfferingPricePerShare
85.00
CY2012 vrx Settlement Of Convertible Debt
SettlementOfConvertibleDebt
606278000 USD
CY2013 vrx Settlement Of Convertible Debt
SettlementOfConvertibleDebt
0 USD
CY2011 vrx Settlement Of Convertible Debt
SettlementOfConvertibleDebt
0 USD
CY2013 vrx Share Based Compensation Arrangement By Share Based Payment Award Number Of Trading Days Average Trading Prices As Base For Calculation For Deferred Compensation
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfTradingDaysAverageTradingPricesAsBaseForCalculationForDeferredCompensation
P5D
CY2013Q2 vrx Sharebased Compensation Expense Increase Decrease Reclassificationof Award
SharebasedCompensationExpenseIncreaseDecreaseReclassificationofAward
-5800000 USD
CY2011 vrx Stock Issued During Period Value Equity Settlement And Reclassification Of Call Options
StockIssuedDuringPeriodValueEquitySettlementAndReclassificationOfCallOptions
66863000 USD
CY2012Q4 vrx Stockholders Equity Before Comprehensive Income Net Of Tax
StockholdersEquityBeforeComprehensiveIncomeNetOfTax
3673203000 USD
CY2013Q4 vrx Stockholders Equity Before Comprehensive Income Net Of Tax
StockholdersEquityBeforeComprehensiveIncomeNetOfTax
6110044000 USD
CY2011Q4 vrx Stockholders Equity Before Comprehensive Income Net Of Tax
StockholdersEquityBeforeComprehensiveIncomeNetOfTax
4150929000 USD
CY2013 vrx Tax Benefit Recognition Measurement Percentage
TaxBenefitRecognitionMeasurementPercentage
0.5
CY2012 vrx Unrecognized Tax Benefits Decrease Resultingfrom Priorand Current Period Tax Positions
UnrecognizedTaxBenefitsDecreaseResultingfromPriorandCurrentPeriodTaxPositions
3400000 USD
CY2013 vrx Unrecognized Tax Benefits Decrease Resultingfrom Priorand Current Period Tax Positions
UnrecognizedTaxBenefitsDecreaseResultingfromPriorandCurrentPeriodTaxPositions
12800000 USD
CY2013Q4 vrx Unrecognized Tax Benefits Including Interest And Penalties
UnrecognizedTaxBenefitsIncludingInterestAndPenalties
247500000 USD
CY2012Q4 vrx Unrecognized Tax Benefits Including Interest And Penalties
UnrecognizedTaxBenefitsIncludingInterestAndPenalties
128000000 USD
CY2012 vrx Unrecognized Tax Benefits Increase Resultingfrom Priorand Current Period Tax Positions
UnrecognizedTaxBenefitsIncreaseResultingfromPriorandCurrentPeriodTaxPositions
29100000 USD
CY2013 vrx Unrecognized Tax Benefits Increase Resultingfrom Priorand Current Period Tax Positions
UnrecognizedTaxBenefitsIncreaseResultingfromPriorandCurrentPeriodTaxPositions
132400000 USD
CY2013 dei Amendment Flag
AmendmentFlag
false
CY2013 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2013 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013 dei Document Period End Date
DocumentPeriodEndDate
2013-12-31
CY2013 dei Document Type
DocumentType
10-K
CY2013 dei Entity Central Index Key
EntityCentralIndexKey
0000885590
CY2014Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
334869413 shares
CY2013 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2013 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2013Q2 dei Entity Public Float
EntityPublicFloat
25293645000 USD
CY2013 dei Entity Registrant Name
EntityRegistrantName
Valeant Pharmaceuticals International, Inc.
CY2013 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2013 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes

Files In Submission

Name View Source Status
0000885590-14-000025-index-headers.html Edgar Link pending
0000885590-14-000025-index.html Edgar Link pending
0000885590-14-000025.txt Edgar Link pending
0000885590-14-000025-xbrl.zip Edgar Link pending
a5yrtotalreturn2013ii.jpg Edgar Link pending
exhibit1018.htm Edgar Link pending
exhibit1019.htm Edgar Link pending
exhibit1028.htm Edgar Link pending
exhibit1036.htm Edgar Link pending
exhibit1037.htm Edgar Link pending
exhibit211.htm Edgar Link pending
exhibit231.htm Edgar Link pending
exhibit232.htm Edgar Link pending
exhibit311.htm Edgar Link pending
exhibit312.htm Edgar Link pending
exhibit321.htm Edgar Link pending
exhibit322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R110.htm Edgar Link pending
R111.htm Edgar Link pending
R112.htm Edgar Link pending
R113.htm Edgar Link pending
R114.htm Edgar Link pending
R115.htm Edgar Link pending
R116.htm Edgar Link pending
R117.htm Edgar Link pending
R118.htm Edgar Link pending
R119.htm Edgar Link pending
R12.htm Edgar Link pending
R120.htm Edgar Link pending
R121.htm Edgar Link pending
R122.htm Edgar Link pending
R123.htm Edgar Link pending
R124.htm Edgar Link pending
R125.htm Edgar Link pending
R126.htm Edgar Link pending
R127.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
valeant2013form10-k.htm Edgar Link pending
vrx-20131231.xml Edgar Link completed
vrx-20131231.xsd Edgar Link pending
vrx-20131231_cal.xml Edgar Link unprocessable
vrx-20131231_def.xml Edgar Link unprocessable
vrx-20131231_lab.xml Edgar Link unprocessable
vrx-20131231_pre.xml Edgar Link unprocessable